Susceptibility of cancer cells to β-lapachone is enhanced by ionizing radiation
- 1 January 2005
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 61 (1) , 212-219
- https://doi.org/10.1016/j.ijrobp.2004.09.018
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Cellular and Molecular Responses to Topoisomerase I Poisons: Exploiting Synergy for Improved RadiotherapyAnnals of the New York Academy of Sciences, 2006
- Chemosensitivity of human prostate cancer cells PC3 and LNCaP to genistein isoflavone and β‐lapachoneBiology of the Cell, 2002
- β-Lapachone-Induced Apoptosis in Human Prostate Cancer Cells: Involvement of NQO1/xip3Experimental Cell Research, 2001
- Calcium Is a Key Signaling Molecule in β-Lapachone-mediated Cell DeathJournal of Biological Chemistry, 2001
- Activation of a Cysteine Protease in MCF-7 and T47D Breast Cancer Cells during β-Lapachone-Mediated ApoptosisExperimental Cell Research, 2000
- NAD(P)H:Quinone Oxidoreductase Activity Is the Principal Determinant of β-Lapachone CytotoxicityJournal of Biological Chemistry, 2000
- Quinone Reductase Inhibitors Block SAPK/JNK and NFκB Pathways and Potentiate ApoptosisPublished by Elsevier ,1999
- Reductase Enzyme Expression Across the National Cancer Institute Tumor Cell Line Panel: Correlation With Sensitivity to Mitomycin C and EO9JNCI Journal of the National Cancer Institute, 1996
- High levels of expression of the NAD(P)H:Quinone oxidoreductase (NQO1) gene in tumor cells compared to normal cells of the same originBiochemical Pharmacology, 1991
- β-Lapachone greatly enhances MMS lethality to human fibroblastsBiochemical and Biophysical Research Communications, 1984